hydroxyurea has been researched along with 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkins, LM; Gale, GR; Meischen, SJ; Schwartz, P | 1 |
Rittberg, DA; Wright, JA | 1 |
Carter, GL; Cory, JG | 1 |
Bacon, PE; Brown, NC; Carter, GL; Cory, JG; Montgomery, JA; Sato, A | 1 |
Bacon, PE; Cory, JG; Sato, A | 1 |
Caras, IW; Eriksson, S; Jones, T; Martin, DW | 1 |
Cory, JG; Sato, A | 1 |
Cory, JG; Lasater, L; Sato, A | 1 |
Cory, AH; Cory, JG; He, AW | 1 |
9 other study(ies) available for hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone
Article | Year |
---|---|
Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.
Topics: Animals; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Guanazole; Hydroxyurea; Isoquinolines; Leukemia L1210; Mice; Platinum; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Thiosemicarbazones | 1979 |
Relationships between sensitivity to hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIO) and ribonucleotide reductase RNR2 mRNA levels in strains of Saccharomyces cerevisiae.
Topics: Blotting, Northern; Hydroxyurea; Isoquinolines; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; RNA, Fungal; RNA, Messenger; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 1989 |
Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Topics: Adenine; Animals; Cell Line; Drug Resistance; Electron Spin Resonance Spectroscopy; Guanidines; Hydroxyurea; Isoquinolines; Leukemia L1210; Pyrazoles; Ribonucleotide Reductases | 1988 |
The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Deoxyadenosines; Deoxyguanosine; Hydroxyurea; Isoquinolines; Leukemia L1210; Models, Biological; Nucleic Acid Synthesis Inhibitors; Phosphorylases; Pyrazoles; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Thymidine; Vidarabine | 1985 |
Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
Topics: Anaerobiosis; Animals; Catalase; Cell Division; Cells, Cultured; Deferoxamine; Guanazole; Humans; Hydroxyurea; Isoenzymes; Isoquinolines; Leukemia L1210; Peroxidase; Peroxidases; Pyrazoles; Quinolines; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Triazoles | 1984 |
Direct photoaffinity labeling of the catalytic site of mouse ribonucleotide reductase by CDP.
Topics: Affinity Labels; Animals; Cytidine Diphosphate; Cytosine Nucleotides; Deoxyribonucleotides; Hydroxyurea; Isoquinolines; Kinetics; Lymphoma; Macromolecular Substances; Mice; Molecular Weight; Neoplasms, Experimental; Ribonucleotide Reductases; Ribonucleotides | 1983 |
Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
Topics: Aldehydes; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Deoxyadenine Nucleotides; Deoxyguanine Nucleotides; Drug Interactions; Drug Synergism; Edetic Acid; Hydroxyurea; Imidazoles; Inosine; Isoquinolines; Mice; Pyrazoles; Ribonucleotide Reductases; Thiosemicarbazones; Thymine Nucleotides | 1981 |
Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Drug Interactions; Drug Synergism; Female; Guanazole; Hydroxyurea; Iron Chelating Agents; Isoquinolines; Mice; Pyrazoles; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Thiosemicarbazones | 1980 |
Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cell Division; Deoxyadenosines; Drug Resistance; Enzyme Inhibitors; Humans; Hydroxyurea; Isoquinolines; Leukemia; Mice; Pyrazoles; Ribonucleotide Reductases; Tumor Cells, Cultured | 1998 |